1. Detrimental or beneficial: the role of TRPM2 in ischemia/reperfusion injury
- Author
-
Wei Yang, Peilin Yu, Chun-hui Liu, Jianhong Luo, and Kaiyu Zhan
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Ischemia ,TRPM Cation Channels ,Myocardial Reperfusion Injury ,Review ,Pharmacology ,Kidney ,Brain Ischemia ,Brain ischemia ,03 medical and health sciences ,Tissue damage ,medicine ,Animals ,Humans ,Pharmacology (medical) ,TRPM2 ,chemistry.chemical_classification ,Reactive oxygen species ,Renal ischemia ,business.industry ,General Medicine ,medicine.disease ,Surgery ,030104 developmental biology ,medicine.anatomical_structure ,chemistry ,Reperfusion Injury ,business ,Reperfusion injury - Abstract
Ischemia/reperfusion (I/R) injury is the main cause of tissue damage and dysfunction. I/R injury is characterized by Ca(2+) overload and production of reactive oxygen species (ROS), which play critical roles in the process of I/R injury to the brain, heart and kidney, but the underlying mechanisms are largely elusive. Recent evidence demonstrates that TRPM2, a Ca(2+)-permeable cationic channel and ROS sensor, is involved in I/R injury, but whether TRPM2 plays a protective or detrimental role in this process remains controversial. In this review, we discuss the recent progress in understanding the role of TRPM2 in reperfusion process after brain, heart and kidney ischemia and the potential of targeting TRPM2 for the development of therapeutic drugs to treat I/R injury.
- Published
- 2016